COMPANY PROFILE · UPDATED 18 NOV 2025

Kura Oncology

Kura Oncology, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovery and development of personalized therapeutics for the treatment of tumors and blood cancers. Kura Oncology offers development…

San Diego, CA · Boston, MA

kuraoncology.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2014
Headcount: 158
Open roles: 8
Last raised: Post Ipo Equity

TECH STACK

How Kura Oncology builds

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Kura Oncology

View all 8 open roles →

FUNDING

Capital raised

Total raised

$1,241,425,536

Investors

Arch Venture Partners Bristol-Myers Squibb Company Cowen Deerfield Management EcoR1 Capital Fidelity Hercules Capital Nextech Invest Osage University Partners II Partner Fund Management Suvretta Capital Management Tavistock Group

Funding rounds

Post Ipo Equity
Diffbot knowledge graph
Suvretta Capital Management, EcoR1 Capital, Deerfield Management
$150MJan 23, 2024
Post Ipo Equity
Diffbot knowledge graph
$100MJun 13, 2023
Post Ipo Equity
Diffbot knowledge graph
Bristol-Myers Squibb Company
$25MNov 2, 2022
Post Ipo Debt
Diffbot knowledge graph
Hercules Capital
$125MNov 2, 2022
Post Ipo Equity
Diffbot knowledge graph
$345.1MDec 7, 2020
Post Ipo Equity
Diffbot knowledge graph
$143.9MMay 5, 2020
Post Ipo Equity
Diffbot knowledge graph
$115.3MJun 17, 2019
Post Ipo Equity
Diffbot knowledge graph
$77.1MJun 27, 2018
Post Ipo Equity
Diffbot knowledge graph
Cowen
$50.1MAug 9, 2017
Post Ipo Equity
Diffbot knowledge graph
$50MOct 27, 2015
Private Equity
Diffbot knowledge graph
EcoR1 Capital, Arch Venture Partners, Nextech Invest, Osage University Partners II, Fidelity, Tavistock Group, Partner Fund Management
$60MMar 11, 2015
IPO
Diffbot knowledge graph
UndisclosedJan 1, 2015